<?xml version="1.0"?>

<document>
	<title>Precipitating antibodies against Escherichia coli, Bacteroides
   fragilis ss.  thetaiotaomicron and Pseudomonas aeruginosa in serum
   from normal persons and cystic fibrosis patients, determined by
   means of crossed immunoelectrophoresis.</title>

	<author>Hoiby-N.</author>
	<author>Hertz-J-B.</author>

	<source>Acta-Paediatr-Scand. 1979 Jul. 68(4). P 495-500.</source>

	<abstract>Serum from normal persons and from 133 cystic fibrosis patients was
   examined for precipitins against faecal bacteria (E. coli and B.
   fragilis) and against P. aeruginosa by means of crossed
   immunoelectrophoresis.  27% of the normal sera contained 1-2
   precipitins against E. coli, 16% contained one precipitin against B.
   fragilis and 6% contained one precipitin against P. aeruginosa.  In
   sera from cystic fibrosis patients, there was a significantly
   increased prevalence of precipitins against E. coli (76%), B.
   fragilis (38%) and P. aeruginosa (63%), and the mean number of
   precipitins against each of these bacteria was 3 (range: 1-12), 1.4
   (range: 1-4), and 16 (range: 1-60), respectively.  Increased numbers
   of precipitins against P. aeruginosa were correlated with chronic
   lung infection caused by this species and with poor prognosis,
   whereas such associations were not revealed as regards precipitins
   against the two other bacterial species.  Increased numbers of
   precipitins against E. coli and B. fragilis were significantly
   associated with increased numbers of precipitins against P.
   aeruginosa.  It is suggested that this association is due to immune
   reactions in the intestinal mucosa, resulting in increased
   absorption of antigens from the gut.</abstract>

	<majorsubject>ANTIBODIES-BACTERIAL</majorsubject>
	<majorsubject>BACTEROIDES-FRAGILIS: im</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>ESCHERICHIA-COLI: im</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: mi</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>MALE</minorsubject>

	<reference>001   BJORNEBOE M           LANCET                           1    58 972</reference>
	<reference>002   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>003   FINEGOLD SM           ANAEROBIC BACTERIA HUMAN DIS             977</reference>
	<reference>004   GIBBONS A             BR MED J                         1   120 976</reference>
	<reference>005   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973</reference>
	<reference>006   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>007   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>008   HOIBY N               SCAND J RESPIR DIS              56    38 975</reference>
	<reference>009   HOIBY N               SCAND J IMMUNOL SUPPL 2          4   187 975</reference>
	<reference>010   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   142 977</reference>
	<reference>011   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     1 977</reference>
	<reference>012   MCFARLANE H           BR MED J                         1   423 975</reference>
	<reference>013   SASAKI M              JAPAN J EXP MED                 45   335 975</reference>
	<reference>014   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978</reference>
	<reference>015   SCHWAB JH             BACT REV                        39   121 975</reference>
	<reference>016   SKIDMORE BJ           J IMMUNOL                      114   770 975</reference>
	<reference>017   THERKELSEN AJ         MEDICINSK STATISTIK AKADEMISK            968</reference>
	<reference>018   TOLO K                IMMUNOLOGY                      33   733 977</reference>
	<reference>019   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974</reference>
	<reference>020   WALLWORK JC           CLIN ALLERGY                     6   349 976</reference>
	<reference>021   WEEKE B               SCAND J IMMUNOL SUPPL 1          2    15 973</reference>
	<reference>022   WEEKE B               SCAND J IMMUNOL SUPPL 1          2    47 973</reference>

	<citation>1   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981</citation>
	<citation>2   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981</citation>
	<citation>3   KOCH C                ALLERGY                         37   191 982</citation>
	<citation>4   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>5   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982</citation>
	<citation>6   BERG RD               EOS RIV IMMUNOL IMMUNOFARMACO    5   161 985</citation>
	<citation>7   GOTZ M                MONATSSCHR KINDERHEILKD        133   718 985</citation>

</document>
